cipamfylline has been researched along with Dermatitis, Irritant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashikaga, T; de Jongh, GJ; Hornix, M; Kucharekova, M; Schalkwijk, J; T'kint, S; van de Kerkhof, PC; van der Valk, PG | 1 |
1 trial(s) available for cipamfylline and Dermatitis, Irritant
Article | Year |
---|---|
The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Betamethasone Valerate; Cell Division; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Irritant; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Erythema; Female; Glucocorticoids; Humans; Keratins; Male; Middle Aged; Pilot Projects; Sodium Dodecyl Sulfate; Surface-Active Agents; Water Loss, Insensible; Xanthines | 2003 |